Found 10 matching trials
A Phase I [18F]THK-5351 Positron Emission Tomography Study in Healthy Subjects and Alzheimer's Disease PHASE1 This is a study to evaluate biodistribution, pharmacokinetics and safety of...
Show More Location
Asan Medical Center
Learn More & Join Trial
Imaging Tau in Alzheimer's Disease and Normal Aging PHASE2 This study is being done to learn about tau tangles in Alzheimer's disease....
Show More Location
Columbia University Medical Center
Learn More & Join Trial
Novel Neuroimage Study in Tauopathies With Parkinsonism PHASE2 The aims of this study are: 18F-THK5351 PET(Positron Emission Tomography) c...
Show More Location
Chang Gung Memorial Hospital,Linkou
Learn More & Join Trial
The Aging Brain and Cognition: Contribution of Vascular Injury, Amyloid Plaque and Tau Protein to Cognitive Dysfunction After Stroke PHASE2 Stroke can lead to signficiant neurological deficits, and about one-third o...
Show More Location
Department of Neurology, Chang-Gung memorial Hospital
Learn More & Join Trial
The Influence of Sequential Tau Protein and Amyloid Plaque Imaging Changes on Stroke Prognosis and Cognitive Outcome PHASE2 Amyloid plaques and tau protein are the landmarks of neurodegeneration in A...
Show More Location
Department of Neurology, Chang-Gung memorial Hospital
Learn More & Join Trial
The Influence of [18F]PMPBB3 and [18F]THK5351 PET Distribution Patterns on Post-stroke Cognitive Impairment PHASE2 Background and objects: Neuroinflammation is an active process detectable i...
Show More Location
Department of Neurology, Chang-Gung memorial Hospital
Learn More & Join Trial
Pathophysiology of Neurodegeneration in Late-life Depression (AV45+THK) PHASE2 Late-life depression has been frequently associated with cognitive impairme...
Show More Location
Chang Gung Memorial Hospital
Learn More & Join Trial
TAU PET Imaging in Northern Manhattan Study of Metabolism and Mind PHASE2 The purpose of this project is to study brain imaging of a substance called...
Show More Location
Columbia University Medical Center
Learn More & Join Trial
[18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative Disease PHASE2 This is a cross-sectional and longitudinal study to evaluate the clinical u...
Show More Location
Asan Medical Center
Learn More & Join Trial
Biodistribution, Pharmacokinetics, and Safety of F-18 THK-5351 PET in Alzheimer's Disease Patients and Healthy Subjects.(Positron Emission Tomograph ) PHASE1 Biodistribution, pharmacokinetics, and safety of F-18 THK-5351 PET in Alzhe...
Show More Location
Multiple Locations
Learn More & Join Trial